A study by Bjornevik et al. (2021) showed that CMV infection enhances the overall repertoire of CD8+ T cells that are cross-reactive to EBV, which may contribute to the suppression of EBV-driven immune dysregulation in MS4. The gene discussed is CD8A; the disease is cytomegalovirus infection.